keyword
https://read.qxmd.com/read/38628415/immune-checkpoint-monoclonal-antibody-related-adverse-effects-in-neuro-ophthalmology
#1
JOURNAL ARTICLE
May Ameri, Nagham Al-Zubidi, Andrew G Lee
Immunotherapy has renovated the field of oncology. Usually, cancer is treated by surgery, chemotherapy, and radiation. Immunotherapy is a promising treatment that harnesses the patient's own immune system to target cancer. Immune checkpoint inhibitors (ICIs) have proven to be a promising treatment avenue for managing cancer; however, their use had been associated with a unique spectrum of adverse side effects called immune-related adverse events (irAEs). As ICIs become increasingly relevant in cancer management, it is crucial to address these irAEs affecting various systems in the body, including the skin, liver, gastrointestinal tract, endocrine system, and the eye...
2024: Saudi Journal of Ophthalmology: Official Journal of the Saudi Ophthalmological Society
https://read.qxmd.com/read/38626261/surgery-for-advanced-neuroendocrine-tumours-of-the-small-bowel-recommendations-based-on-a-consensus-meeting-of-the-european-society-of-endocrine-surgeons-eses
#2
JOURNAL ARTICLE
Klaas Van Den Heede, Dirk-Jan van Beek, Sam Van Slycke, Inne Borel Rinkes, Olov Norlén, Peter Stålberg, Erik Nordenström
BACKGROUND: Small bowel neuroendocrine tumours often present with locally advanced or metastatic disease. The aim of this paper is to provide evidence-based recommendations regarding (controversial) topics in the surgical management of advanced small bowel neuroendocrine tumours. METHODS: A working group of experts was formed by the European Society of Endocrine Surgeons. The group addressed 11 clinically relevant questions regarding surgery for advanced disease, including the benefit of primary tumour resection, the role of cytoreduction, the extent of lymph node clearance, and the management of an unknown primary tumour...
April 3, 2024: British Journal of Surgery
https://read.qxmd.com/read/38623382/iron-metabolic-biomarkers-and-the-mortality-risk-in-the-general-population-a-nationwide-population-based-cohort-study
#3
JOURNAL ARTICLE
Yuanyuan Sun, Wenyao Peng, Siqi Lin, Jingjing Cui, Jiapeng Lu
CONTEXT: Iron is an essential element in the human body and plays a critical role in many physiological and cellular processes. However, the association between iron status and the risk of all-cause or cause-specific mortality has not been well-investigated. And it is unclear whether the association between iron metabolic biomarkers and the risk of mortality differs between people with and without diabetes mellitus (DM). OBJECTIVE: This work aimed to investigate associations between iron metabolic biomarkers and all-cause and cause-specific mortality risk in the general population, and heterogeneities in the associations among population with and without DM...
April 6, 2024: Journal of the Endocrine Society
https://read.qxmd.com/read/38623381/diet-in-food-insecurity-a-mediator-of-metabolic-health
#4
JOURNAL ARTICLE
Lisa L Morselli, Rabia Amjad, Roland James, Tammy L Kindel, Anne E Kwitek, Joni S Williams, Justin L Grobe, Srividya Kidambi
OBJECTIVE: Food insecurity (FI) is associated with poor metabolic health. It is assumed that energy intake and diet quality underlie this association. We tested the hypothesis that dietary factors (quantity and quality) mediate the association of FI with excess weight, waist circumference and glycemic control [glycohemoglobin (A1C)]. METHODS: A mediation analysis was performed on data from the National Health And Nutrition Examination Survey using FI as an independent variable; body mass index (BMI), waist circumference, and A1C as metabolic outcome variables and total energy intake, macronutrients, and diet quality measured by the Healthy Eating Index-2015 (HEI-2015) as potential mediators...
April 6, 2024: Journal of the Endocrine Society
https://read.qxmd.com/read/38623380/thyroid-hormones-and-diabetes-in-euthyroid-hispanic-latino-adults-of-diverse-backgrounds-hchs-sol
#5
JOURNAL ARTICLE
Victoria Persky, Chibuzor Abasilim, Konstantina Tsintsifas, Tessa Day, Robert M Sargis, Martha Daviglus, Jianwen Cai, Sally Freels, Robert Kaplan, Carmen R Isasi, Amber Pirzada, Michelle L Meyer, Gregory A Talavera, Bharat Thyagarajan, Shivani Agarwal, Noel Chavez, Arielle Grieco, Mary E Turyk
CONTEXT: Previous studies have demonstrated associations of endogenous thyroid hormones with diabetes; less is known about stages of diabetes development at which they are operative, mechanisms of associations, and the role of the hypothalamic-pituitary-thyroid axis. OBJECTIVE: This study examined associations of thyroid hormones with incident prediabetes and diabetes and with changes in glycemic traits in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL), the largest cohort of Hispanic/Latino adults with diverse backgrounds in the United States...
April 6, 2024: Journal of the Endocrine Society
https://read.qxmd.com/read/38622851/use-of-approved-lu-177-radiopharmaceuticals-in-patients-with-end-stage-renal-disease-a-review-of-the-literature-and-proposed-treatment-algorithm
#6
JOURNAL ARTICLE
Nikolaos A Trikalinos, Hyun Kim, Anitha Vijayan, Maxwell Amurao, Vikas Prasad
Peptide receptor radionuclide therapy (PRRT) can be a very useful treatment for patients with neuroendocrine neoplasms and metastatic castration-resistant prostate cancer but it is routinely avoided in those with advanced kidney disease because it can adversely affect the renal function. Accordingly, no clear guidelines exist on the use of PRRT for patients on hemodialysis (HD). We performed a literature review to identify publications on HD patients who received PRRT with Lutetium-177 (Lu177 ) Dotatate and Y-90 and obtained information on Lu177 pharmacokinetics and early testing data from the manufacturer...
April 15, 2024: Journal of Neuroendocrinology
https://read.qxmd.com/read/38622315/management-of-surgical-diseases-of-primary-hyperparathyroidism-indications-of-the-united-italian-society-of-endocrine-surgery-siuec
#7
JOURNAL ARTICLE
Paolo Del Rio, Marco Boniardi, Loredana De Pasquale, Giovanni Docimo, Maurizio Iacobone, Gabriele Materazzi, Fabio Medas, Michele Minuto, Barbara Mullineris, Andrea Polistena, Marco Raffaelli, Pietro Giorgio Calò
A task force of the United Italian society of Endocrine Surgery (SIUEC) was commissioned to review the position statement on diagnostic, therapeutic and health‑care management protocol in parathyroid surgery published in 2014, at the light of new technologies, recent oncological concepts, and tailored approaches. The objective of this publication was to support surgeons with modern rational protocols of treatment that can be shared by health-care professionals, taking into account important clinical, healthcare and therapeutic aspects, as well as potential sequelae and complications...
April 15, 2024: Updates in Surgery
https://read.qxmd.com/read/38617813/from-fundamentals-to-the-clinic-advancing-obesity-research-in-endocrinology
#8
EDITORIAL
Zeynep Madak-Erdogan, Stephen R Hammes, M Furkan Burak
No abstract text is available yet for this article.
April 6, 2024: Journal of the Endocrine Society
https://read.qxmd.com/read/38617812/3-18-f-fluoro-para-hydroxyphenethylguanidine-3-18-f-phpg-pet-a-novel-imaging-modality-for-paraganglioma
#9
JOURNAL ARTICLE
Tobias Else, Ka Kit Wong, Kirk A Frey, Allen F Brooks, Benjamin L Viglianti, David M Raffel
CONTEXT: Functional positron emission tomography (PET) imaging for the characterization of pheochromocytoma and paraganglioma (PCC/PGL) and for detection of metastases in malignant disease, offers valuable clinical insights that can significantly guide patient treatment. OBJECTIVE: This work aimed to evaluate a novel PET radiotracer, 3-[18 F]fluoro- para -hydroxyphenethylguanidine (3-[18 F]pHPG), a norepinephrine analogue, for its ability to localize PCC/PGL. METHODS: 3-[18 F]pHPG PET/CT whole-body scans were performed on 16 patients (8 male:8 female; mean age 47...
April 6, 2024: Journal of the Endocrine Society
https://read.qxmd.com/read/38614801/treatment-of-hypercalcaemia-of-malignancy-in-adults
#10
JOURNAL ARTICLE
Darran Mc Donald, Matthew T Drake, Rachel K Crowley
Hypercalcaemia of malignancy (HCM) is a common metabolic complication of advanced malignancies with a prevalence varying from 2-30%, depending on cancer type and disease stage. HCM is associated with impaired quality of life, increased risk of hospitalisation and limited survival. Evidence-based guidelines for management of HCM have been lacking to date, despite its prevalence and detrimental impact. This concise guidance highlights key recommendations from the recent Endocrine Society Clinical Practice Guidelines on Treatment of Hypercalcaemia of Malignancy in Adults, published in December 2022...
September 2023: Clinical Medicine: Journal of the Royal College of Physicians of London
https://read.qxmd.com/read/38613937/use-of-herbal-medication-in-the-perioperative-period-potential-adverse-drug-interactions
#11
REVIEW
Ofelia Loani Elvir Lazo, Paul F White, Carol Lee, Hillenn Cruz Eng, Jenna M Matin, Cory Lin, Franklin Del Cid, Roya Yumul
Use of herbal medications and supplements has experienced immense growth over the last two decades, with retail sales in the USA exceeding $13 billion in 2021. Since the Dietary Supplement Health and Education Act (DSHEA) of 1994 reduced FDA oversight, these products have become less regulated. Data from 2012 shows 18% of U.S. adults used non-vitamin, non-mineral natural products. Prevalence varies regionally, with higher use in Western states. Among preoperative patients, the most commonly used herbal medications included garlic, ginseng, ginkgo, St...
April 12, 2024: Journal of Clinical Anesthesia
https://read.qxmd.com/read/38609072/association-of-phthalate-exposure-with-reproductive-outcomes-among-infertile-couples-undergoing-in-vitro-fertilization-a-systematic-review
#12
REVIEW
Tian Xiangming, Qin Boyi, Yang Li, Li Huanhuan, Wenhui Zhou
Human fertility is impacted by changes in lifestyle and environmental deterioration. To increase human fertility, assisted reproductive technology (ART) has been extensively used around the globe. As early as 2009, the Endocrine Society released its first scientific statement on the potential adverse effects of environmental endocrine-disrupting chemicals (EDCs) on human health and disease development. Chemicals known as phthalates, frequently employed as plasticizers and additives, are common EDCs. Numerous studies have shown that phthalate metabolites in vivo exert estrogen-like or anti-androgenic effects in both humans and animals...
April 10, 2024: Environmental Research
https://read.qxmd.com/read/38606557/use-of-empirical-medical-therapies-for-idiopathic-male-infertility-in-australia-and-new-zealand
#13
JOURNAL ARTICLE
Sarah R Catford, Darren Katz, Robert I McLachlan
OBJECTIVE: Idiopathic male infertility is common, yet there is no approved treatment. This study aimed to understand practice patterns towards empirical medical therapy (EMT) for idiopathic male infertility in Australia and New Zealand (NZ). DESIGN: Clinical members of the Endocrine Society of Australia, Fertility Society of Australia & NZ, and Urological Society of Australia & NZ were invited to complete a survey. Questions included demographics, EMT practice habits, and thoughts regarding infertility case scenarios...
April 12, 2024: Clinical Endocrinology
https://read.qxmd.com/read/38604051/endocrine-metabolic-assessment-checklist-for-cancer-patients-treated-with-immunotherapy-a-proposal-by-the-italian-association-of-medical-oncology-aiom-italian-association-of-medical-diabetologists-amd-italian-society-of-diabetology-sid-italian-society-of-endocrinology
#14
REVIEW
Maria Chiara Zatelli, Antongiulio Faggiano, Antonella Argentiero, Romano Danesi, Stella D'Oronzo, Stefano Fogli, Tindara Franchina, Francesco Giorgino, Nicola Marrano, Dario Giuffrida, Stefania Gori, Giampiero Marino, Rossella Mazzilli, Matteo Monami, Monica Montagnani, Lelio Morviducci, Annalisa Natalicchio, Alberto Ragni, Valerio Renzelli, Antonio Russo, Laura Sciacca, Enzo Tuveri, Gianluca Aimaretti, Angelo Avogaro, Riccardo Candido, Massimo Di Maio, Nicola Silvestris, Marco Gallo
Immunotherapy with immune checkpoint inhibitors (ICI) is increasingly employed in oncology. National and international endocrine and oncologic scientific societies have provided guidelines for the management of endocrine immune-related adverse events. However, guidelines recommendations differ according to the specific filed, particularly pertaining to recommendations for the timing of endocrine testing. In this position paper, a panel of experts of the Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE), and Italian Society of Pharmacology (SIF) offers a critical multidisciplinary consensus for a clear, simple, useful, and easily applicable endocrine-metabolic assessment checklist for cancer patients on immunotherapy...
April 3, 2024: Cancer Treatment Reviews
https://read.qxmd.com/read/38601785/clinical-and-metabolic-characterization-of-women-with-gestational-diabetes-mellitus-within-the-first-year-postpartum
#15
JOURNAL ARTICLE
Laura Løftgaard Knudsen, Sine Knorr, Susanne Kastberg Prange, Charlotte Wolff, Helle Nørgaard, Anne Mette Torp, Lene Ring Madsen, Lene Mortensen, Henrik Holm Thomsen, Lars Peter Sørensen, Per Glud Ovesen, Jens Fuglsang, Ulla Kampmann
CONTEXT: Women with gestational diabetes mellitus (GDM) have an increased risk of long-term complications, including impaired glucose metabolism, type 2 diabetes (T2DM), cardiovascular disease, and obesity. In current clinical practice, a 1 size fits all approach to GDM is applied, although heterogeneity among women with GDM has been recognized. OBJECTIVE: To give the most adequate preventive care and postpartum (PP) guidance, we aimed to make a metabolic characterization and identify subgroups of women with previous GDM within the first year PP...
April 6, 2024: Journal of the Endocrine Society
https://read.qxmd.com/read/38601289/evolution-of-breast-conserving-surgery-current-implementation-of-oncoplastic-techniques-in-breast-conserving-surgery-a-literature-review
#16
REVIEW
Inés Torras, Isaac Cebrecos, Helena Castillo, Eduard Mension
BACKGROUND AND OBJECTIVE: De-escalation in breast cancer surgery has been a natural evolution since breast conserving surgery (BCS) was introduced in the early 1980s. From Halsted mastectomies to wide local excisions, we are facing nowadays the next trend in form of oncoplastic breast surgery. Oncoplastic breast surgery combines oncological principles with plastic surgery techniques to preserve the breast shape and appearance. The aim of this work is to review recent oncological and quality of live outcomes derived from oncoplastic techniques as well as offer a perspective about its implementation in breast cancer units...
March 27, 2024: Gland Surgery
https://read.qxmd.com/read/38599049/oral-serds-alone-or-in-combination-with-cdk-4-6-inhibitors-in-breast-cancer-current-perspectives-and-clinical-trials
#17
REVIEW
Kleoniki Apostolidou, Eleni Zografos, Maria Alkistis Papatheodoridi, Oraianthi Fiste, Meletios Athanasios Dimopoulos, Flora Zagouri
Over the past few decades, first-line therapy for treating advanced and metastatic HR+/HER2-breast cancer has transformed due to the introduction of adjuvant endocrine therapy with cyclin-dependent kinase 4/6 inhibitors (CDK 4/6i). However, there is an unmet need for novel classes of endocrine therapy with superior efficacy to improve treatment outcomes and overcome CDK4/6i resistance. New generation selective estrogen receptor degraders (SERDs), orally administered and with higher bioavailability, could potentially be the novel compounds to meet this emerging need...
April 4, 2024: Breast: Official Journal of the European Society of Mastology
https://read.qxmd.com/read/38599048/the-impact-of-symptom-clusters-on-endocrine-therapy-adherence-in-patients-with-breast-cancer
#18
JOURNAL ARTICLE
Sommer Agnew, Megan Crawford, Iain MacPherson, Victor Shiramizu, Leanne Fleming
BACKGROUND: When taken as prescribed, endocrine therapy is effective in reducing risk of recurrence and mortality in the treatment of patients with breast cancer. However, treatment side effects can act as a barrier to medication adherence. Existing research has not identified any specific side effects as consistent predictors of nonadherence. Our aim was to explore the influence of symptom clusters on self-reported adherence in patients with breast cancer. METHODS: A cross-sectional online survey was conducted, including patients with breast cancer currently or previously prescribed endocrine therapy (N = 1051)...
April 6, 2024: Breast: Official Journal of the European Society of Mastology
https://read.qxmd.com/read/38599047/radiological-pathological-and-surgical-outcomes-after-neoadjuvant-endocrine-treatment-in-patients-with-er-positive-her2-negative-breast-cancer-with-a-clinical-high-risk-and-a-low-risk-70-gene-signature
#19
JOURNAL ARTICLE
Josefien P van Olmen, Chaja F Jacobs, Sanne A L Bartels, Claudette E Loo, Joyce Sanders, Marie-Jeanne T F D Vrancken Peeters, Caroline A Drukker, Frederieke H van Duijnhoven, Marleen Kok
OBJECTIVE: This study aims to evaluate the response to and surgical benefits of neoadjuvant endocrine therapy (NET) in ER+/HER2-breast cancer patients who are clinically high risk, but genomic low risk according to the 70-gene signature (MammaPrint). METHODS: Patients with ER+/HER2-invasive breast cancer with a clinical high risk according to MINDACT, who had a genomic low risk according to the 70-gene signature and were treated with NET between 2015 and 2023 in our center, were retrospectively analyzed...
April 5, 2024: Breast: Official Journal of the European Society of Mastology
https://read.qxmd.com/read/38596879/prevalence-of-infertility-and-barriers-to-family-building-among-male-physicians
#20
JOURNAL ARTICLE
Jasmine S Lin, Justin M Dubin, Jonathan Aguiar, Robert E Brannigan, Joshua A Halpern
BACKGROUND: Fertility declines with increasing age and physicians often delay childbearing beyond prime reproductive years for the sake of medical training. However, the risks of infertility in male physicians compared to the general population remain poorly studied. OBJECTIVES: To characterize rates of infertility among male physicians and identify barriers in access to fertility care and family building. MATERIALS & METHODS: Between June 2022 and December 2022, male physicians were invited to complete a questionnaire regarding fertility and family building...
April 10, 2024: Andrology
keyword
keyword
108489
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.